ATE296801T1 - Tetrahydrobezindol derivate - Google Patents

Tetrahydrobezindol derivate

Info

Publication number
ATE296801T1
ATE296801T1 AT97928490T AT97928490T ATE296801T1 AT E296801 T1 ATE296801 T1 AT E296801T1 AT 97928490 T AT97928490 T AT 97928490T AT 97928490 T AT97928490 T AT 97928490T AT E296801 T1 ATE296801 T1 AT E296801T1
Authority
AT
Austria
Prior art keywords
group
lower alkyl
hydrogen atom
carbamoyl
alkoxycarbonyl
Prior art date
Application number
AT97928490T
Other languages
English (en)
Inventor
Masao Koyama
Chika Kikuchi
Osamu Ushiroda
Takashi Ando
Hiroshi Nagaso
Kazuyuki Fuji
Masayo Okuno
Toyokazu Hiranuma
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Application granted granted Critical
Publication of ATE296801T1 publication Critical patent/ATE296801T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/90Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • C07D209/92Naphthostyrils
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AT97928490T 1996-06-28 1997-06-27 Tetrahydrobezindol derivate ATE296801T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP16970296 1996-06-28
JP9627197 1997-04-15
JP13020197 1997-05-21
JP14437697 1997-06-03
PCT/JP1997/002226 WO1998000400A1 (en) 1996-06-28 1997-06-27 Tetrahydrobenzindole compounds

Publications (1)

Publication Number Publication Date
ATE296801T1 true ATE296801T1 (de) 2005-06-15

Family

ID=27468418

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97928490T ATE296801T1 (de) 1996-06-28 1997-06-27 Tetrahydrobezindol derivate

Country Status (8)

Country Link
US (1) US6355642B1 (de)
EP (1) EP0937715B1 (de)
JP (1) JP4076234B2 (de)
AT (1) ATE296801T1 (de)
DE (1) DE69733427T2 (de)
ES (1) ES2243999T3 (de)
NO (1) NO311515B1 (de)
WO (1) WO1998000400A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69829317T2 (de) 1997-12-25 2006-04-06 Meiji Seika Kaisha Ltd. Tetrahydrobenzindol-derivate
WO1999054303A1 (en) * 1998-04-22 1999-10-28 Meiji Seika Kaisha, Ltd. Optically active tetrahydrobenzindole derivatives
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
GB9828004D0 (en) * 1998-12-18 1999-02-10 Smithkline Beecham Plc Use
EP1222185A1 (de) * 1999-10-18 2002-07-17 Smithkline Beecham Plc Tetrahydrobenzindolon-derivate, deren herstellung und deren verwendung als 5-ht7 rezeptor antagonisten
JP2004231514A (ja) * 2000-08-31 2004-08-19 Meiji Seika Kaisha Ltd 5−ht7受容体結合能を有し、かつ代謝的に安定なテトラヒドロベンズインドール誘導体
ITRM20010356A1 (it) * 2001-06-21 2002-12-23 Sigma Tau Ind Farmaceuti "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina.
US7786094B2 (en) * 2001-10-09 2010-08-31 Biopolymer Engineering, Inc. Use of beta-glucans against biological warfare weapons and pathogens including anthrax
EP1676840A1 (de) 2004-12-28 2006-07-05 Laboratorios Del Dr. Esteve, S.A. 5-HT7-Rezeptorantagonisten
US7553965B2 (en) 2002-11-07 2009-06-30 Laboratories Del Dr. Esteve, S.A. 5-HT7 receptor antagonists
AU2004265243A1 (en) * 2003-06-20 2005-02-24 Arena Pharmaceuticals, Inc. N-phenyl-piperazine derivatives and methods of prophylaxis or treatment of 5HT2c receptor associated diseases
MXPA06003150A (es) 2003-09-17 2006-08-31 Johnson & Johnson Compuestos heterociclicos fusionados.
HRP20060402A2 (hr) * 2004-05-11 2007-06-30 Egis Gy�gyszergy�r Nyrt. Derivati piridina alkilnih oksindola kao 5-ht7 receptorski aktivni agensi
WO2006064780A1 (ja) * 2004-12-14 2006-06-22 Shionogi & Co., Ltd. 便秘治療剤
EP1902044A1 (de) * 2005-07-07 2008-03-26 Bio Medisinsk Innovasjon AS 5-htx-modulatoren
CN102295636A (zh) 2005-07-29 2011-12-28 弗·哈夫曼-拉罗切有限公司 吲哚-3-基-羰基-哌啶和哌嗪衍生物
US7598255B2 (en) * 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
US5077293A (en) * 1990-06-29 1991-12-31 Bristol-Myers Squibb Co. 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines
JP3190858B2 (ja) 1997-07-23 2001-07-23 山形日本電気株式会社 半導体装置およびその製造方法

Also Published As

Publication number Publication date
US6355642B1 (en) 2002-03-12
EP0937715B1 (de) 2005-06-01
JP4076234B2 (ja) 2008-04-16
EP0937715A4 (de) 2001-01-17
NO986141D0 (no) 1998-12-28
ES2243999T3 (es) 2005-12-01
DE69733427D1 (de) 2005-07-07
NO311515B1 (no) 2001-12-03
WO1998000400A1 (en) 1998-01-08
NO986141L (no) 1999-02-17
DE69733427T2 (de) 2006-04-27
EP0937715A1 (de) 1999-08-25

Similar Documents

Publication Publication Date Title
DE69733427D1 (de) Tetrahydrobezindol derivate
WO2006067165A3 (en) Indolidone derivatives for the treatment or prevention of fibrotic diseases
PH12021551256A1 (en) Pantetheine derivatives and uses thereof
GEP20053600B (en) 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors
MY138352A (en) Benzothiazole derivatives
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
KR950700258A (ko) 레티노이드 수용체(rar)에 결합하는 헤테로고리 탄산유도체(heterocyclic carbonic acid derivatives which bind to retinoid receptors(rar))
AUPR213700A0 (en) Antiviral agents
NO20020968L (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
ATE384058T1 (de) Thiazolderivate
EA200501703A1 (ru) Применение производных азетидинкарбоксамида в терапии
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
IL195016A0 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
ATE210118T1 (de) N-(3-piperidinylcarbonyl)-b-alanin derivate als paf-antagonisten
MXPA01007940A (es) Derivados de azabicicloalcano y usos terapeuticos de los mismos.
TW200716547A (en) Piperidin-4-yl-amide derivatives
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
EP1750703A4 (de) Verfahren zur verringerung der gastrointestinalen toxizität durch verabreichung von tegafur
DE69512816D1 (de) Oxopyridylchinoxalin Derivate
TW200626571A (en) Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
NO964497D0 (no) Middel for behandling av cor pulmonale
EA200600891A1 (ru) Нитроксипроизводные гипотензивных лекарственных средств
IT1313583B1 (it) Derivati 2-amminotetralinici per la terapia del glaucoma.
AU2003264940A1 (en) Pyrazole derivatives and their use as therapeutic agents for hiv mediated diseases
GB2316944A (en) New catechol derivatives

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties